Literature DB >> 287195

Penicillamine induced membranous glomerulonephritis.

G H Neild, H V Gärtner, A Bohle.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1979        PMID: 287195     DOI: 10.3109/03009747909108243

Source DB:  PubMed          Journal:  Scand J Rheumatol Suppl        ISSN: 0301-3847


× No keyword cloud information.
  7 in total

Review 1.  Immunotoxic side-effects of drug therapy.

Authors:  J A Mitchell; E M Gillam; L A Stanley; E Sim
Journal:  Drug Saf       Date:  1990 May-Jun       Impact factor: 5.606

2.  Penicillamine nephropathy.

Authors: 
Journal:  Br Med J (Clin Res Ed)       Date:  1981-03-07

Review 3.  Antirheumatic drugs: clinical pharmacology and therapeutic use.

Authors:  G L Craig; W W Buchanan
Journal:  Drugs       Date:  1980-12       Impact factor: 9.546

Review 4.  Drug-induced nephrotoxicity. Aetiology, clinical features and management.

Authors:  A J Hoitsma; J F Wetzels; R A Koene
Journal:  Drug Saf       Date:  1991 Mar-Apr       Impact factor: 5.606

Review 5.  Penicillamine in rheumatoid arthritis. A problem of toxicity.

Authors:  H G Taylor; A Samanta
Journal:  Drug Saf       Date:  1992 Jan-Feb       Impact factor: 5.606

6.  Progressive proliferative glomerulonephritis in a patient with rheumatoid arthritis treated with D-penicillamine.

Authors:  A J Williams; J N Fordham; C G Barnes; F J Goodwin
Journal:  Ann Rheum Dis       Date:  1986-01       Impact factor: 19.103

7.  Historical perspectives on penicillamine.

Authors:  L Fernandes; H Berry; E Hamilton
Journal:  J R Coll Physicians Lond       Date:  1980-04
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.